Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Roger Bedimo(The University of Texas Southwestern Medical Center), Pamela S. Douglas(Duke University), Michael T. Lu(Cancer Research And Biostatistics), Mamta K. Jain(The University of Texas Southwestern Medical Center), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Estebán Martínez(Instituto de Salud Carlos III), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Jorge Pinto(Universidade Federal de Minas Gerais), Philip E. Castle(National Cancer Institute), Aya Awwad(Harvard University), Markella V. Zanni(Harvard University), Jose Narrea(Asociación Civil Impacta Salud y Educación), Bronwyn Hendricks(University of Cape Town)
Cited by 3
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k